may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful.
bother for hernandez stemmed in july 2017, when she suffered a stroke that left her partially blind, which her.
the report was compiled by outside researchers who went into the fda�s own database of �serious adverse [medical-drug] events.�